News | Point-of-Care Ultrasound (POCUS) | February 09, 2022

Philips Expands Ultrasound Portfolio with Handheld POCUS

Philips point-of-care ultrasound technology now includes Pulse Wave Doppler for all physicians – from cardiologists and radiologists to emergency care – to quickly assess hemodynamics in cardiac function anytime, anywhere

With the addition of Pulse Wave Doppler [1], Philips has greatly expanded the utility of its Handheld Ultrasound – Lumify – enabling clinicians to quantify blood flow in a wide range of point-of-care diagnostic applications – including cardiology, vascular, abdominal, urology, obstetrics and gynecology.

February 9, 2022 — Philips, a global leader in health technology, announced it has expanded its ultrasound portfolio with advanced hemodynamic assessment and measurement capabilities on its handheld point-of-care ultrasound – Lumify. With the addition of Pulse Wave Doppler [1], Philips has greatly expanded the utility of its Handheld Ultrasound – Lumify – enabling clinicians to quantify blood flow in a wide range of point-of-care diagnostic applications – including cardiology, vascular, abdominal, urology, obstetrics and gynecology. Also new to Lumify are obstetric measurements to help in early assessment of gestational age and the identification of high-risk pregnancies.

Point-of-care hemodynamics

Pulse Wave Doppler ultrasound provides clinicians with more information, in addition to 2D and color imaging, to assess hemodynamic patterns to differentiate between arterial and venous blood flow and quantify hemodynamic function. The resulting hemodynamic measurements can  enhance diagnostic confidence and timely clinical decision-making in virtually any care setting, including cardiology and emergency medicine. With these latest features, Philips’ easy-to-use fully integrated handheld ultrasound system – Lumify – brings together imaging tools across ultrasound platforms, leveraging the company’s expertise in cardiology and radiology. The Lumify system also provides clinicians with advanced analysis software and reporting tools, and access to tele-ultrasound capabilities (Lumify with Collaboration Live powered by Reacts) for live communication support to connect clinicians around the globe for real-time collaboration.

“By applying Philips’ expertise in cardiovascular care, imaging and patient monitoring to Philips Handheld Ultrasound – Lumify – we are committed to deliver a dedicated, innovative point-of-care portfolio, enabling clinicians to quickly assess hemodynamics – including cardiovascular function, organ perfusion and fetal assessment – in a daily routine, to identify abnormalities and intervene quickly,” said Matthijs Groot Wassink, General Manager of Point of Care Ultrasound at Philips. “With the addition of Pulse Wave Doppler and enhanced obstetrics measurements, we have increased the number of markers on which diagnoses can be made, to deliver high quality imaging and enhance the evaluation and effectiveness of treatment in real-time.”

“Having Color Flow Doppler (CFD) and Pulse Wave Doppler on a handheld device is game changing, allowing clinicians to take point-of-care ultrasound examinations to the next level,” said Dr. Robert Jones, Professor of Emergency Medicine at the MetroHealth System, Cleveland, Ohio in the U.S.A. Dr. Jones will discuss the clinical advantages and benefits of integrating CFD and Pulse Wave Doppler into the point-of-care ultrasound evaluation of acutely ill and injured patients in the Emergency Department in an upcoming webinar.

Philips B-lines software enhances heart and lung assessments in handheld ultrasound

In addition to adding Pulse Wave Doppler for hemodynamics, Philips is the first and only point-of-care ultrasound solution with B-lines (B-line quantification tool for ultrasound lung imaging) software and intelligent algorithms to enhance heart and lung assessments, which is critical when dealing with severe COVID cases. The pandemic has shown the relevance of lung ultrasound in the diagnosis and treatment of pneumonia, one of the most common complications of COVID-19. AI-enhanced automated algorithms looking for B-lines in lung fluid can help provide more objective data and interpretation.

Increased access to quality care

The continuous scanning, performance and portability of Philips Handheld Ultrasound – Lumify – brings a full diagnostic solution to care professionals at the bedside; both in and outside of the hospital. The innovative technology is also in widespread use in community-based mother and child care programs, providing access to quality healthcare for underserved communities worldwide, including a program in Kenya driven by the Philips Foundation to educate midwives to deliver ultrasound-based antenatal pregnancy screening in village clinics, while receiving telehealth support from radiologists at distance.

For more information:

[1] Pulse Wave Doppler measurement is currently available on the Android Lumify app. Availability on the Apple iOS/ iPad iOS Lumify app is scheduled for the future.

Find more cardiac ultrasound news 

Find more point-of-care-ultrasound (POCUS) news 

FDA Clears Fully Automated Cardiac Ultrasound Solution to Measure 2D and Doppler

Related Ultrasound  Technology Content From the Past Year:

Handheld Ultrasound Used to Monitor COVID-19 Patients With Cardiac Complications

Point-of-care Ultrasound Sees Rapid Growth Amid COVID-19 and May be Poised for Consumers

FDA Clears AI-powered Cardiac Ultrasound Analysis and Quantification by Ultromics

VIDEO: Imaging COVID-19 With Point-of-Care Ultrasound (POCUS) — Interview with Mike Stone, M.D.

Philips Expands Cardiovascular Ultrasound With Affiniti CVx to Increase Productivity


Intel and Samsung Medison Announce AI Ultrasound Technology for Fetal Care

Fujifilm Sonosite Receives FDA COVID-19 510(k) Clearance for Comprehensive POCUS Portfolio

Utility of Point-of-Care Ultrasound Across Clinical Applications Spurs Continued Growth

Ultrasound Systems Market to Outpace Other Imaging Modalities for COVID-19 Diagnostics

FDA Clears Philips Ultrasound Portfolio to Image COVID-19 Related Lung and Cardiac Complications


Atrium Health and Butterfly Network Partner for Innovation in Medical Imaging During COVID-19

AI-Guided Ultrasound System Now Available in the U.S.

Emagine Solutions Technology Receives FDA 510(k) Clearance for VistaScan Mobile Ultrasound

FDA Clears Artificial Intelligence to Guide User for Optimal Cardiac Ultrasound Imaging

Philips 3-D Ultrasound Offers New Surveillance Method for Abdominal Aortic Aneurysms

Exact Therapeutics Announces Innovative Probe Development Collaboration With GE Healthcare

FDA Clears Ultromics Echocardiography AI for Auto Identification of Coronary Artery Disease

Samsung Introduces Its Latest Radiology Innovations

Konica Minolta Debuts Next-generation Ultrasound System, the SONIMAGE HS2

Expanded AI-based Echocardiography Analysis and Reporting Added to Konica Minolta Exa Cardio PACS 


DiA Granted FDA Clearance for its Cardiac Ultrasound AI Auto Views Selection

Northwestern Medicine Introduces Artificial Intelligence to Improve Ultrasound Imaging

Aplio i-Series and Aplio a-series Ultrasound Deliver Streamlined Workflow and Optimal Ergonomics

VIDEO: AI Features on the GE Voluson Swift Ultrasound System

Butterfly Network Releases New Version of Point-of-Care Ultrasound Platform With Butterfly iQ+

GE Healthcare Receives FDA Clearance for AI-powered Cardiovascular Ultrasound System

VIDEO: Arietta 850SE Continues Deliverin Quality Ultrasound 

Related Content

News | Hemodynamic Support Devices

October 23, 2023 — Supira Medical, Inc., a Shifamed portfolio company, announced that the company's percutaneous ...

Home October 23, 2023
News | Hemodynamic Support Devices

November 1, 2022 — Abiomed announced that Impella RP Flex with SmartAssist has received U.S. Food and Drug ...

Home November 01, 2022
News | Hemodynamic Support Devices

September 17, 2022 — Results of a new per-protocol analysis of the ST-segment Elevation Myocardial Infarction Door-To ...

Home September 17, 2022
News | Hemodynamic Support Devices

November 12, 2020 — Abiomed recently announced new PROTECT III study data that demonstrates reduced rates of MACCE ...

Home November 12, 2020
Videos | Hemodynamic Support Devices

Chuck Simonton, M.D., chief medical officer at Abiomed, discusses some of the new technologies and clinical trials the ...

Home October 20, 2020
News | Hemodynamic Support Devices

October 16, 2020 — The Restore EF Study demonstrates the use of contemporary best practices, including attempting a more ...

Home October 16, 2020
News | Hemodynamic Support Devices

July 16, 2020 – The U.S. Food and Drug Administration (FDA) approved one-way digital data streaming during patient ...

Home July 16, 2020
News | Hemodynamic Support Devices

June 5, 2020 — Abiomed announced the U.S. Food and Drug Administration (FDA) has approved the company's investigational ...

Home June 05, 2020
Videos | Hemodynamic Support Devices

This is a quick animation demonstrating how the new 9 French Abiomed Impella ECP expands to approximately 18 French and ...

Home June 05, 2020
Subscribe Now